Article
Gene therapy for muscular dystrophy: lessons learned and path forward.
Neuroscience letters - 11 Oct 2012
Mendell Jerry R, Rodino-Klapac Louise, Sahenk Zarife, Malik Vinod, Kaspar Brian K, Walker Christopher M, Clark K Reed
Abstract excerpt
Our Translational Gene Therapy Center has used small molecules for exon skipping and mutation suppression and gene transfer to replace or provide surrogate genes as tools for molecular-based approaches for the treatment of muscular dystrophies. Exon skipping is targeted at the pre-mRNA level allowing one or more exons to be omitted to restore the reading frame. In Duchenne Muscular Dystrophy (DMD), clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
